TY - JOUR
KW - Addiction
KW - buprenorphine
KW - Opiate
KW - Opioid
KW - Overdose
KW - Population health
AU - Christopher W. Jones
AU - Zachary Christman
AU - Christopher M. Smith
AU - Michelle R. Safferman
AU - Matthew Salzman
AU - Kaitlan Baston
AU - Rachel Haroz
A1 - 
AD - Cooper Medical School of Rowan University, Department of Emergency Medicine, One Cooper Plaza, Camden, NJ 08103, USA. Electronic address: jones-christopher@cooperhealth.edu.; Department of Geography, Planning, and Sustainability, Rowan University, 201 Mullica Hill Road, Glassboro, NJ 08028, USA. Electronic address: christmanz@rowan.edu.; Cooper Medical School of Rowan University, Department of Emergency Medicine, One Cooper Plaza, Camden, NJ 08103, USA. Electronic address: smith-christopher@CooperHealth.edu.; Cooper Medical School of Rowan University, Department of Emergency Medicine, One Cooper Plaza, Camden, NJ 08103, USA. Electronic address: saffermam7@rowan.edu.; Cooper Medical School of Rowan University, Department of Emergency Medicine, One Cooper Plaza, Camden, NJ 08103, USA. Electronic address: Salzman-Matthew@CooperHealth.edu.; Cooper Medical School of Rowan University, Department of Internal Medicine, Three Cooper Plaza, Camden, NJ 08103, USA. Electronic address: Baston-Kaitlan@CooperHealth.edu.; Cooper Medical School of Rowan University, Department of Emergency Medicine, One Cooper Plaza, Camden, NJ 08103, USA. Electronic address: haroz-rachel@CooperHealth.edu.
BT - Journal of substance abuse treatment
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CY - United States
DO - 10.1016/j.jsat.2018.07.008
JF - Journal of substance abuse treatment
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PP - United States
PY - 2018
SN - 1873-6483; 0740-5472
SP - 19
EP - 25
EP - 
T1 - Comparison between buprenorphine provider availability and opioid deaths among US counties
T2 - Journal of substance abuse treatment
TI - Comparison between buprenorphine provider availability and opioid deaths among US counties
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 30126537
U3 - 10.1016/j.jsat.2018.07.008
VL - 93
VO - 1873-6483; 0740-5472
Y1 - 2018
Y2 - Oct
ER -